For neuroblastomas with low ALK expression, an ALK inhibitor can increase ALK expression on tumor cells by preventing ALK internalization and degradation, thereby enhancing CAR-T cell-mediated cytotoxicity against tumors [40]. Here, ALK is linked to neoplasm.